Calidi Biotherapeutics, Inc. Derivative Liability, Current
Calidi Biotherapeutics, Inc. (CLDI) had Derivative Liability, Current of $273.45 thousand as of 2023-06-30, per its 10-Q filed 2023-08-21.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:DerivativeLiabilitiesCurrent · last filed 2023-08-21
- 2023-06-30: Derivative Liability, Current $273.45K.
- 2023-03-31: Derivative Liability, Current $134.27K.
- 2022-12-31: Derivative Liability, Current $32.87K.
- 2021-12-31: Derivative Liability, Current $0.00.
| Period end | Derivative Liability, Current |
|---|---|
| 2023-06-30 | $273.45K 10-Q · filed 2023-08-21 |
| 2023-03-31 | $134.27K 10-Q · filed 2023-05-15 |
| 2022-12-31 | $32.87K 10-Q · filed 2023-08-21 |
| 2021-12-31 | $0.00 10-K · filed 2023-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |